The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 16, 2016

Filed:

Mar. 15, 2013
Applicant:

Bender Analytical Holding B.v., Overasselt, NL;

Inventors:

Johannes Caspar Mathias Elizabeth Bender, Overasselt, NL;

Richard Hoogenboom, Terneuzen, NL;

Jan Cornelis Maria Van Hest, Nijmegen, NL;

Harry Van Goor, Heilig Landstichting, NL;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C08G 73/02 (2006.01); A61L 27/18 (2006.01); C08L 79/02 (2006.01); A61L 31/10 (2006.01); A61L 17/10 (2006.01); A61L 24/04 (2006.01); C08J 3/075 (2006.01); C08J 3/24 (2006.01);
U.S. Cl.
CPC ...
C08G 73/0233 (2013.01); A61L 17/10 (2013.01); A61L 24/046 (2013.01); A61L 27/18 (2013.01); A61L 31/10 (2013.01); C08G 73/02 (2013.01); C08L 79/02 (2013.01); C08J 3/075 (2013.01); C08J 3/246 (2013.01); C08J 2379/02 (2013.01); C08L 2312/00 (2013.01);
Abstract

One aspect of the invention relates to a biocompatible medical product comprising at least 1% by weight of dry matter of a covalently cross-linked polymer that is obtained by reacting a nucleophilically activated polyoxazoline (NU-POX) with an electrophilic cross-linking agent other than an electrophilically activated polyoxazoline, said NU-POX comprising m nucleophilic groups; and said electrophilic cross-linking agent comprising n electrophilic groups, wherein the m nucleophilic groups are capable of reaction with the n electrophilic groups to form covalent bonds; wherein m≧2, n≧2 and m+n≧5; and wherein the NU-POX comprises at least 30 oxazoline units in case the electrophilic cross-linking agent is an isocyanate. Also provided is a kit for producing the aforementioned biocompatible cross-linked polymer. The biocompatible cross-linked polymers according to the invention have excellent implant and/or sealing characteristics.


Find Patent Forward Citations

Loading…